September 22-25, 2026 as part of Biotech Week Boston
Hynes Convention CenterBoston, USA Hugh GannonAssociate Director at KSQ TherapeuticsSpeaker
Profile
Hugh Gannon, PhD is a scientist in the field of gene-edited cell therapies, specializing in CRISPR-based genome engineering and analytical development. His work focuses on developing and implementing assays to support sgRNA manufacturing, potency characterization, and regulatory readiness. He has deep experience in translating functional genomics insights into robust, scalable workflows for clinical-stage programs, with particular emphasis on ensuring consistency, quality, and performance of gene editing reagents.
Agenda Sessions
Enabling sgRNA Release and Stability Testing with a ddPCR-Based Potency Assay
, 9:30amView Session